Study Says Drug Cuts Cholesterol and Reduces Heart Attacks - But It’s Not Cheap


A study paid for by the drug maker of Repatha found that it can have huge benefits on patients, but the price tag is steep: $14,000 per year.

Your Playlist Expand Collapse

Full Episodes of Nightly News

Inspiring America

Keeping you Healthy

The Price You Pay

Nightly Films